Health TrialsbyHealthPanel

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

ConditionsNeoplasmsArteriovenous Malformation of Central Nervous SystemTrigeminal Neuralgia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorThe Radiosurgery Society

About this trial

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy

Willingness to sign an Informed Consent Document or verbally agree to participation

Disqualifiers

There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

Trial population

Any patients who have a SRS/SBRT procedure

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • SRS/SBRT

    Radiation

    Intervention varies by condition being treated.

Treatment groups

50,000 Participants
are divided into 1 treatment group
Group A: Patients being treated by SRS/SBRT1 intervention

Trial outcomes

Primary outcomes

1

Overall survival

Survival from time of treatment to death

Time frame
Up to 5 years

Secondary outcomes

1

Local and distant recurrence

Calculated from time of treatment to recurrence

Time frame
One to Five years

Other outcomes

1

Treatment toxicity

Complications of treatment. These complications are organ specific depending on which organ is being treated. For example, if the prostate is being treated,there may be rectal and urinary complications. If the brain is being treated, there may be headaches or nausea. The Radiation Therapy Oncology Group (RTOG) scale used for defining and measuring complications of radiotherapy is incorporated into the Registry database.

Time frame
Immediate -5 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Radiosurgery Society

Lead sponsor

VisionTree

Collaborator

Source ClinicalTrials.gov
Apply now